Michigan Compiled Laws Act 345 Of 2014 Right To Try Act (333.26451 - 333.26457)

AN ACT to authorize access to and use of experimental treatments for patients with an advanced illness; to establish conditions for use of experimental treatment; to prohibit sanctions of health care providers solely for recommending or providing experimental treatment; to clarify duties of a health insurer with regard to experimental treatment authorized under this act; to prohibit certain actions by state officials, employees, and agents; and to restrict certain causes of action arising from experimental treatment.

History: 2014, Act 345, Imd. Eff. Oct. 17, 2014

Section 333.26451 Short Title; Definitions.
(1) This act shall be known and may be cited as the "right to try act". (2) As used in this act, and unless...
Section 333.26452 Availability Of Investigational Drug, Biological Product, Or Device.
(1) A manufacturer of an investigational drug, biological product, or device may make available and an eligible patient may request the manufacturer's investigational drug,...
Section 333.26453 Coverage By Health Plan, Third Party Administrator, Or Governmental Agency; Costs; New Or Additional Services Provided By Hospital Or Facility.
(1) This act does not expand the coverage required of an insurer under the insurance code of 1956, 1956 PA 218, MCL 500.100 to...
Section 333.26454 Outstanding Debt Related To Treatment Or Lack Of Insurance; Liability Of Patient's Heirs.
If a patient dies while being treated by an investigational drug, biological product, or device, the patient's heirs are not liable for any outstanding...
Section 333.26455 Licensing Board Or Disciplinary Committee; Prohibitions; Medicare Certification Entity; Prohibitions.
A licensing board or disciplinary subcommittee shall not revoke, fail to renew, suspend, or take any action against a health care provider's license issued...
Section 333.26456 Access To Investigational Drug, Biological Product, Or Device.
An official, employee, or agent of this state shall not block or attempt to block an eligible patient's access to an investigational drug, biological...
Section 333.26457 Private Cause Of Action; Participation In Clinical Trials.
(1) This act does not create a private cause of action against a manufacturer of an investigational drug, biological product, or device or against...

Last modified: October 10, 2016